Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases May 7, 2026 Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis May 6, 2026 Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 1, 2026 Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease All press releases Latest Events May 19 2026 May 19 2026 RBC Global Healthcare Conference Click here for Webcast May 13 2026 May 13 2026 BofA Securities Health Care Conference Click here for Webcast Apr 28 2026 Apr 28 2026 Q1 2026 Incyte Corporation Earnings Conference Call Click here for Webcast All events
